UiPath (PATH) – Investment Analysts’ Recent Ratings Changes

A number of research firms have changed their ratings and price targets for UiPath (NYSE: PATH):

• 9/24/2026 – UiPath had its “sector weight” rating reaffirmed by KeyCorp.
• 9/24/2026 – UiPath was given a new $15.00 price target by New Street Research.
• 9/24/2026 – UiPath had its price target lowered by Canaccord Genuity Group Inc. from $17.00 to $14.00. They now have a “hold” rating on the stock.
• 9/24/2026 – UiPath had its price target lowered by BMO Capital Markets from $18.00 to $15.00. They now have a “market perform” rating on the stock.
• 9/23/2026 – UiPath had its “outperform” rating reaffirmed by Royal Bank Of Canada.
• 9/23/2026 – UiPath had its “buy” rating reaffirmed by UBS Group AG.
• 9/23/2026 – UiPath had its price target lowered by Truist Financial Corporation from $17.00 to $14.00. They now have a “hold” rating on the stock.
• 9/23/2026 – UiPath had its “hold” rating reaffirmed by TD Cowen. They now have a $16.00 price target on the stock.
• 9/23/2026 – UiPath had its price target lowered by UBS Group AG from $19.00 to $15.00. They now have a “neutral” rating on the stock.
• 9/23/2026 – UiPath had its price target lowered by Royal Bank Of Canada from $17.00 to $15.00. They now have a “sector perform” rating on the stock.
• 9/23/2026 – UiPath had its “buy” rating reaffirmed by Needham & Company LLC. They now have a $22.00 price target on the stock.
• 9/9/2026 – UiPath was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”.
• 9/8/2026 – UiPath is now covered by Citigroup Inc.. They set a “buy” rating and a $23.00 price target on the stock.
• 9/8/2026 – UiPath is now covered by Citigroup Inc.. They set a “buy” rating and a $23.00 price target on the stock.
• 9/4/2026 – UiPath had its price target raised by Royal Bank Of Canada from $15.00 to $17.00. They now have a “sector perform” rating on the stock.
• 9/4/2026 – UiPath had its price target raised by Barclays PLC from $14.00 to $17.00. They now have an “equal weight” rating on the stock.
• 9/4/2026 – UiPath had its “buy” rating reaffirmed by HC Wainwright.
• 9/4/2026 – UiPath had its “market perform” rating reaffirmed by Oppenheimer Holdings, Inc..
• 9/4/2026 – UiPath was given a new $16.00 price target by UBS Group AG.
• 9/4/2026 – UiPath had its price target raised by TD Cowen from $13.00 to $16.00. They now have a “hold” rating on the stock.
• 9/4/2026 – UiPath had its “hold” rating reaffirmed by Canaccord Genuity Group Inc.. They now have a $17.00 price target on the stock, up from $15.00.
• 9/4/2026 – UiPath had its price target raised by Truist Financial Corporation from $12.00 to $17.00. They now have a “hold” rating on the stock.
• 9/4/2026 – UiPath had its price target raised by Mizuho from $12.00 to $14.00. They now have a “neutral” rating on the stock.
• 9/4/2026 – UiPath had its price target raised by Bank of America Corporation from $13.00 to $15.00. They now have an “underperform” rating on the stock.
• 9/4/2026 – UiPath had its price target raised by Wells Fargo & Company from $13.00 to $15.00. They now have an “equal weight” rating on the stock.
• 9/4/2026 – UiPath had its price target raised by DA Davidson from $12.00 to $16.00. They now have a “neutral” rating on the stock.
• 9/4/2026 – UiPath had its price target raised by BMO Capital Markets from $13.00 to $18.00. They now have a “market perform” rating on the stock.
• 9/3/2026 – UiPath had its price target raised by Needham & Company LLC from $15.00 to $22.00. They now have a “buy” rating on the stock.
• 8/31/2026 – UiPath had its price target raised by UBS Group AG from $12.00 to $19.00. They now have a “neutral” rating on the stock.
• 8/14/2026 – UiPath had its price target raised by Royal Bank Of Canada from $12.00 to $15.00. They now have a “sector perform” rating on the stock.

Insider Activity at UiPath

In other news, insider Raghavendra Malpani sold 40,464 shares of the company’s stock in a transaction dated Thursday, September 17th. The shares were sold at an average price of $14.00, for a total value of $566,496.00. Following the completion of the sale, the insider directly owned 1,582,213 shares of the company’s stock, valued at approximately $22,150,982. This represents a 2.49% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Daniel Dines sold 1,402,347 shares of the stock in a transaction dated Wednesday, August 19th. The stock was sold at an average price of $16.07, for a total transaction of $22,535,716.29. Following the sale, the chief executive officer owned 26,491,238 shares of the company’s stock, valued at $425,714,194.66. This trade represents a 5.03% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 1,560,150 shares of company stock worth $24,727,357 in the last 90 days. 22.44% of the stock is owned by insiders.

UiPath Inc (NYSE: PATH) develops enterprise automation software designed to help organizations automate repetitive, rules-based and increasingly complex business processes. Its platform combines robotic process automation (RPA), artificial intelligence, workflow orchestration and process intelligence to support automation across areas such as finance, customer service, human resources, information technology and operations.

The UiPath Platform includes tools for discovering and analyzing business processes, building and managing software robots, processing documents, testing applications and coordinating automated workflows.